
How drugmakers can reap value from using generative AI in their market-entry strategies and decision-making, including mitigating launch challenges and enhancing the customer conversation.
Vice President, Offering Development, Global Commercial Solutions, IQVIA
Published: August 15th 2024 | Updated: